Ann Cardiovasc Surg | Volume 5, Issue 1 | Case Report | Open Access

Preoperative Use of Sodium Glucose Transporter 2 Inhibitors and Life-Threatening Euglycemic Diabetic Ketoacidosis in Immediate Cardiac Postoperative Care

Isack Iskhakov1, Frank Rosell2, Yelena Friedman3, Adam Lackey1, Arash Salemi1,4 and Iosif Gulkarov1,4*

1Department of Surgery, Jersey City Medical Center, USA
2Department of Cardiothoracic Surgery, Staten Island University Hospital, USA 3Staten Island University Hospital, USA 4Department of Surgery, Rutgers New Jersey Medical School, USA

*Correspondance to: Iosif Gulkarov 

Fulltext PDF

Abstract

One of the major focuses of immediate postoperative cardiac care is the acid-base status of the patient, as it can be a reflection of inadequate perfusion secondary to poor cardiac function. Significant effort is being made to maintain ideal blood pH as it allows for optimization of cardiac function in the early cardiac postoperative period. In this case report we describe association of sodium glucose transporter 2 inhibitors used in the treatment of diabetes with euglycemic diabetic ketoacidosis postoperatively despite being held 72 h prior to surgery. As is demonstrated in our case, early recognition and treatment are essential in prevention and treatment of acidosis in this vulnerable group of patients.

Keywords:

Euglycemic ketoacidosis; Cardiac surgery; Sodium glucose transporter 2 inhibitor; SGLT2i; Diabetic ketoacidosis

Citation:

Iskhakov I, Rosell F, Friedman Y, Lackey A, Salemi A, Gulkarov I. Preoperative Use of Sodium Glucose Transporter 2 Inhibitors and Life- Threatening Euglycemic Diabetic Ketoacidosis in Immediate Cardiac Postoperative Care. Ann Cardiovasc Surg. 2022;5(1):1030..

Subscribe to Our Newsletter